Inflammatory disorders

ERS: Mepolizumab is glucocorticoid-sparing in asthma

(HealthDay)—For patients with eosinophilic asthma, mepolizumab has a glucocorticoid-sparing effect and reduces exacerbations when administered intravenously or subcutaneously, according to two studies published online Sept. ...

Diseases, Conditions, Syndromes

September peak month for kids' asthma flares, study finds

(HealthDay)— Many parents know that allergies are seasonal, but fewer may realize that the same is true of asthma: A new study suggests the riskiest time for children with asthma is September, as they head back to school.

Immunology

Bronchial thermoplasty shows long-term effectiveness for asthma

The beneficial effects of bronchial thermoplasty, a non-pharmacologic treatment for asthma, last at least five years, according to researchers at National Jewish Health and other institutions. The therapy, in which heat is ...

Inflammatory disorders

Severe asthma patients less responsive to treatment

People with severe asthma, who are often described as 'steroid-dependent', are actually less likely to respond to the treatment they depend on, when compared to people with mild asthma.

Health

Traffic pollution and wood smoke increases asthma in adults

(Medical Xpress)—Asthma sufferers frequently exposed to heavy traffic pollution or smoke from wood fire heaters, experienced a significant worsening of symptoms, a new University of Melbourne led study has found.

page 4 from 7